Behavioral Intervention to Reduce Stress Among Black Gender Minority Women
3 other identifiers
interventional
40
1 country
1
Brief Summary
The research objectives of this study are to first, develop a culturally informed community-based intervention with guidance from community members (via focus groups and theater testing) to reduce the effect of chronic stigma exposure on psychological distress symptoms (PTS and depressive symptoms) among transgender women. Second, the research team will conduct a proof-of-concept trial to determine the feasibility and preliminary efficacy of the resulting intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2022
CompletedFirst Posted
Study publicly available on registry
June 28, 2022
CompletedStudy Start
First participant enrolled
May 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 30, 2026
January 1, 2026
2.6 years
June 15, 2022
January 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Intervention Retention Rate
number screened per month; number enrolled per month and per source; rate of eligibility ≥40%); (≥50% retention rate; reasons for dropouts; acute crisis or avoidance behaviors; incentive structure);
Throughout the intervention (up to 12 weeks)
Average time delay from screening to enrollment and average time to enroll enough participants to form cohorts
The average time it takes for participants to be screened and complete enrollment depending on the study cohorts
From screening to Baseline
Overall attendance/adherence
Session attendance ≥67%; online engagement with educational material via click counts
2 weeks post-intervention
Changes in the intervention fidelity
Fidelity rates within and between interventionists; range from 0-3, with 2 or higher indicative of high fidelity per domain via the Seeking Safety Adherence Scale (SASS). Tailoring of the SASS will be based on the format used to deliver the intervention content and the focus of the content. For example, the original scale has the following items that may not be appropriate for the created intervention: "Focused on how the topic related to substance use; Gave handouts and made use of them during the session." Thus, these items may be removed or modified to align with content delivery and subject matter. The SASS will be used to periodically assess the fidelity of intervention delivery among each interventionist. Mean scores will be compared between interventionists and scores below 80% will require remediation in the form of individual training with the PI and the interventionist.
Throughout the intervention (up to 12 weeks)
Changes in the proportion of acceptability
assessment acceptability will be assessed by calculating the proportion of planned assessments that are completed and satisfaction ratings ≥75%; duration of assessment visits; reasons for dropouts);
Baseline, Mid-intervention (3-6 weeks from baseline assessment), 2 weeks post intervention, 3 months post-intervention
Changes in the Intervention acceptability
intervention acceptability (acceptability ≥75%; qualitative assessments; reasons for dropouts; preference/satisfaction ratings ≥75% via Client satisfaction questionnaire); Client satisfaction questionnaire (CSQ-8; Cronbach's alpha .93; 8-item; 4-point Likert) will be administered at the end of every intervention session to address individual session utility and at T3 for overall satisfaction
Throughout the intervention (up to 2 weeks post-intervention)
Accessibility of the intervention
intervention accessibility (qualitative assessments; reasons for dropouts and adherence; technological literacy; ability to access reliable internet). There is no scale for this instrument.
Throughout the intervention (up to 2 weeks post-intervention)
Secondary Outcomes (2)
Change in PTSD symptoms
Baseline, Mid-intervention (3-6 weeks from baseline assessment) , 2 weeks post intervention, 3 months post-intervention
Change in Beck Depression Inventory II (BDI-II)
Baseline, Mid-intervention (3-6 weeks from baseline assessment), 2 weeks post intervention, 3 months post-intervention
Other Outcomes (8)
Changes in the transgender community connection scale (TCC)
Baseline, Mid-intervention (3-6 weeks from baseline assessment), 2 weeks post intervention, 3 months post-intervention
Changes in the multidimensional scale of perceived social support (MSPSS)
Baseline, Mid-intervention (3-6 weeks from baseline assessment), 2 weeks post intervention, 3 months post-intervention
Changes in the coping strategies inventory short form (CSI-SF)
Baseline, Mid-intervention (3-6 weeks from baseline assessment), 2 weeks post intervention, 3 months post-intervention
- +5 more other outcomes
Study Arms (1)
intervention educational content
EXPERIMENTALThe base intervention design will contain educational content informed by the Transgender Resilience Intervention Model (TRIM) and adapted from Seeking Safety specific to a) identifying symptoms of psychological distress, b) managing symptoms via coping (individual resilience), and c) developing a social network and using social support/community connection (group resilience).
Interventions
This is an adaptive intervention approach with 7 module-based sessions selected on the basis of post-session assessments of acceptability and satisfaction; 1. weekly group sessions will be co-led by a community member with expertise in working with transgender women and a public health nurse, 2. supplemental educational content will be available for individual consumption via an online portal or application (and tracked via participant click counts), and 3. additional social resources will be available through the online portal or app.
Eligibility Criteria
You may qualify if:
- years or older
- gender is woman/transgender feminine/female
- assigned male sex at birth
- speak/read English
You may not qualify if:
- Enrolled in mental health treatment or a controlled consequential environment (e.g. mental health transitional living environment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute of Nursing Research (NINR)collaborator
- Emory Universitylead
Study Sites (1)
Emory University School of Nursing
Atlanta, Georgia, 30322, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Athena DF Sherman, PhD, PHN, RN
Emory University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 15, 2022
First Posted
June 28, 2022
Study Start
May 2, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 30, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). Beginning 3 months and ending 5 years following article publication
- Access Criteria
- Researchers who provide a methodologically sound proposal to achieve aims in the approved proposal. Proposals should be directed to adfsherman@emory.edu. To gain access, data requestors will need to sign a data access agreement. Data are available for 5 years at a third-party website (Link to be determined).
The research team will share Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).